PTGS2 and ovarian carcinoma: From these results, it was suggested that PPARγ activation might suppress COX-2 expression via the nuclear factor-κB pathway in the ovarian carcinoma cells and that low expression of PPARγ and high expression of COX-2 might be involved in carcinogenesis and progression of ovarian tumours.